Iressa hopes turn sour for AstraZeneca
Iressa was supposed to be the dream drug for advanced lung cancer patients and its developer, AstraZeneca. Known as a molecular targeting drug, which pinpoints and attacks cancer cells, Iressa
Iressa was supposed to be the dream drug for advanced lung cancer patients and its developer, AstraZeneca. Known as a molecular targeting drug, which pinpoints and attacks cancer cells, Iressa